Save the Date!
Wednesday, May 1, 2024 is MACEP's Annual Meeting
Wednesday, May 1, 2024 is MACEP's Annual Meeting
CONTACT INFORMATION
Sophia Andoscia
Area Manager
Sophia.Andoscia@cslbehring.com
COMPANY INFORMATION
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions, such as coagulation disorders, primary immune deficiencies, hereditary angioedema and respiratory disease.
PRODUCT INFORMATION
Kcentra® Information
Highlighlights of Prescribing Information
Kcentra® Clinical Practice Guidelines
Kcentra®- the only FDA-approved alternative to plasma for urgent warfarin reversal